12:00 AM
Mar 04, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Dyax preclinical data

In rats, subcutaneous DX-2930 reduced carrageenan-induced paw edema vs. vehicle-treated controls. In non-human primates, the half-life of DX-2930 was 12.5 days. Data were presented at the American Academy of Allergy,...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >